Medidata and Cognizant enter into a strategic alliance to offer clients comprehensive solutions that leverage Mediata's cloud platform with Cognizant's business and technology services.
As part of a multi-year agreement between Cognizant and Medidata, Cognizant’s expertise in business process, technology and digital services (including biostats, automation and help desks) will combine with solutions across the Medidata platform with the aim of providing clinical capabilities as-a-service to address the increasing complexities and global scale of clinical trials.
Examples include Randomization and Trial Supply Management, as well as Medidata Site Payments, which will seamlessly connect with Cognizant’s Shared Investigator Platform (SIP).
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.